BioCryst to Present at Upcoming Investor Conference
Rhea-AI Summary
BioCryst (Nasdaq:BCRX) will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 12:00 p.m. ET.
The event will be available via a live audio webcast with a replay. Investors can access the live audio and replay in the Investors & Media section at www.biocryst.com.
Positive
- None.
Negative
- None.
News Market Reaction 4 Alerts
On the day this news was published, BCRX gained 6.07%, reflecting a notable positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $86M to the company's valuation, bringing the market cap to $1.51B at that time.
Data tracked by StockTitan Argus on the day of publication.
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 12:00 p.m. ET.
The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
Investors:
investorrelations@biocryst.com
Media:
media@biocryst.com
FAQ
When will BioCryst (BCRX) present at the Jefferies Global Healthcare Conference?
How can investors access the BioCryst (BCRX) presentation on November 19, 2025?
Will there be a replay of the BioCryst (BCRX) Jefferies presentation?
What format is the BioCryst (BCRX) presentation at the Jefferies conference?
Where on BioCryst's website will the November 19, 2025 presentation be posted?
